Search Results 261-270 of 17036 for colorectal dysplasia

  1. Lynch syndrome - Diagnosis and treatment - Mayo Clinic

    Learn about this condition caused by inherited genes that increase the risk of colon cancer, endometrial cancer and other kinds of cancer.

  2. Colon and Rectal Surgery - Doctors - Mayo Clinic

    1 for digestive disorders in the U.S. News & World Report Best Hospitals rankings. Mayo Clinic in Phoenix/Scottsdale, Arizona, and Mayo Clinic in Jacksonville, ...

  3. A Study of Grapiprant and Pembrolizumab in Patients with Advanced or Progressive MSS Colorectal Cancer - Mayo Clinic

    Clinical Trials · A Study of Grapiprant and Pembrolizumab in Patients with Advanced or Progressive MSS Colorectal Cancer · More about research at Mayo Clinic.

  4. Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer - Mayo Clinic

    ... colorectal cancer that is: negative for RAS wild-type colorectal cancer and has spread to other places in the body, and/or cannot be removed by surgery, and ...

  5. DNA (cfDNA) Blood Test to Detect KRAS and Other Clinically Relevant Gene Mutations in Patients with Metastatic Colorectal Cancer

    KRAS gene mutations are present in approximately 40% of colorectal cancers and are known to predict for a lack of benefit from some anti-cancer medications ( ...

  6. Gerardo Colon-Otero, M.D. - Mayo Clinic Faculty Profiles

    The research of Gerardo Colon-Otero, M.D., is focused on the treatment of breast cancer and gynecologic malignancies (ovarian cancer, uterine cancer and ...

  7. Mayo Clinic expert calls for public health measures to improve diet, reduce cancer risk

    ROCHESTER, Minn. — A review article by Mayo Clinic researchers emphasizes that early onset colorectal cancer, defined as being diagnosed when younger than ...

  8. Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177) - Mayo Clinic

    About this study. In this study, participants with MSI-H or dMMR advanced colorectal carcinoma will be randomly assigned to receive either pembrolizumab or ...

  9. Clinical trials - Gastroenterology and Hepatology

    This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma ...

  10. Back-to-school recommendations / eye floaters / colorectal cancer screening guidelines - Mayo Clinic News Network

    Back-to-school recommendations / eye floaters / colorectal cancer screening guidelines. Aug. 8, 2020. Show Coverart. Donate.